EP Patent

EP4321154A1 — A tablet of tolvaptan and at least one binder processed with spray granulation

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2024-02-14 · 2y expired

What this patent protects

The present invention relates to a tablet comprising an intragranular composition comprising tolvaptan and at least one binder, wherein the intragranular composition is obtained by spray granulation with a solution comprising water and binder.

USPTO Abstract

The present invention relates to a tablet comprising an intragranular composition comprising tolvaptan and at least one binder, wherein the intragranular composition is obtained by spray granulation with a solution comprising water and binder.

Drugs covered by this patent

Patent Metadata

Patent number
EP4321154A1
Jurisdiction
EP
Classification
—
Expires
2024-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.